215 related articles for article (PubMed ID: 17192126)
1. Intensive reduction of low-density lipoprotein-cholesterol: implications of recent trials.
Hackam DG
Am J Cardiovasc Drugs; 2006; 6(6):367-71. PubMed ID: 17192126
[TBL] [Abstract][Full Text] [Related]
2. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
Evans M; Roberts A; Davies S; Rees A
Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
[TBL] [Abstract][Full Text] [Related]
3. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.
Nissen SE; Tuzcu EM; Schoenhagen P; Crowe T; Sasiela WJ; Tsai J; Orazem J; Magorien RD; O'Shaughnessy C; Ganz P;
N Engl J Med; 2005 Jan; 352(1):29-38. PubMed ID: 15635110
[TBL] [Abstract][Full Text] [Related]
4. The power of statins: aggressive lipid lowering.
Jones PH
Postgrad Med; 2002 Oct; 112(4 Suppl):23-30. PubMed ID: 19667597
[TBL] [Abstract][Full Text] [Related]
5. Lipid management for the prevention of cardiovascular disease.
Schaefer JR
Curr Pharm Des; 2011; 17(9):852-60. PubMed ID: 21418030
[TBL] [Abstract][Full Text] [Related]
6. [First comparison of 2 statins shows: only radical LDL lowering stops coronary atherosclerosis].
Einecke D
MMW Fortschr Med; 2003 Dec; 145(51-52):38. PubMed ID: 14974329
[No Abstract] [Full Text] [Related]
7. HDL-C: role as a risk modifier.
Barter P
Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280
[TBL] [Abstract][Full Text] [Related]
8. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.
Sahebkar A; Watts GF
Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550
[TBL] [Abstract][Full Text] [Related]
9. Statins targeting inflammation by lowering low-density lipoprotein?
Tuzcu EM; Nicholls SJ
J Am Coll Cardiol; 2007 May; 49(20):2010-2. PubMed ID: 17512356
[No Abstract] [Full Text] [Related]
10. Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
Colquhoun D; Keech A; Hunt D; Marschner I; Simes J; Glasziou P; White H; Barter P; Tonkin A;
Eur Heart J; 2004 May; 25(9):771-7. PubMed ID: 15120888
[TBL] [Abstract][Full Text] [Related]
11. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
[TBL] [Abstract][Full Text] [Related]
12. [Statins for cardiovascular prevention. Lowering LDL cholesterol, the primary objective].
Fruchart JC
Presse Med; 2002 Sep; 31(30):1428-33. PubMed ID: 12378980
[TBL] [Abstract][Full Text] [Related]
13. [LDL cholesterol--why lower and lower?].
Müller-Wieland D; Kotzka J
MMW Fortschr Med; 2007 May; 149(22):28-30. PubMed ID: 18069223
[TBL] [Abstract][Full Text] [Related]
14. [Statins in primary prevention of coronary heart disease].
Paulweber B
Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of statins in acute coronary syndromes.
Foody JM; Nissen SE
Am J Cardiol; 2001 Aug; 88(4A):31F-5F. PubMed ID: 11520485
[TBL] [Abstract][Full Text] [Related]
16. Lack of accurate evidence on non-statin medication in patients receiving highintensity statin therapy: Re-evaluation of recommendations is needed.
Demirci D; Ersan Demirci D
Anatol J Cardiol; 2018 Mar; 19(3):230. PubMed ID: 29521324
[No Abstract] [Full Text] [Related]
17. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
18. Rationale for targeting multiple lipid pathways for optimal cardiovascular risk reduction.
Ballantyne CM
Am J Cardiol; 2005 Nov; 96(9A):14K-19K; discussion 34K-35K. PubMed ID: 16291009
[TBL] [Abstract][Full Text] [Related]
19. Lipid management with statins. The lower the better?
Laufs U; Liao JK; Böhm M
Z Kardiol; 2004 Jan; 93(1):4-9. PubMed ID: 14740235
[TBL] [Abstract][Full Text] [Related]
20. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
